Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26573069

Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2015 Dec 20
First author
Casali PG

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Casali PG
      type
      Author
    2. name
      Le Cesne A
      type
      Author
    3. name
      Poveda Velasco A
      type
      Author
    4. name
      Kotasek D
      type
      Author
    5. name
      Rutkowski P
      type
      Author
    6. name
      Hohenberger P
      type
      Author
    7. name
      Fumagalli E
      type
      Author
    8. name
      Judson IR
      type
      Author
    9. name
      Italiano A
      type
      Author
    10. name
      Gelderblom H
      type
      Author
    11. name
      Adenis A
      type
      Author
    12. name
      Hartmann JT
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Casali PG
      type
      Author
    2. name
      Le Cesne A
      type
      Author
    3. name
      Poveda Velasco A
      type
      Author
    4. name
      Kotasek D
      type
      Author
    5. name
      Rutkowski P
      type
      Author
    6. name
      Hohenberger P
      type
      Author
    7. name
      Fumagalli E
      type
      Author
    8. name
      Judson IR
      type
      Author
    9. name
      Italiano A
      type
      Author
    10. name
      Gelderblom H
      type
      Author
    11. name
      Adenis A
      type
      Author
    12. name
      Hartmann JT
      type
      Author
    bibliography ids
    1. nci-bib-3bb6f479a5a28a40dbcfa4fb
    book metadata
    content sha256
    6e3d256efc880bb822e894d00b991e6ada932775638ca3549fff69aee42f740b
    document type
    citation
    dois
    1. 10.1200/JCO.2015.62.4304
    electronic publication date
    display
    2015 Nov 16
    precision
    day
    year
    2015
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:26573069
    immutable id
    pubmed:26573069@6e3d256efc880bb822e894d00b991e6ada932775638ca3549fff69aee42f740b
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    36
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    4276-83
    volume
    33
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      26573069
      provenance
      batch id
      948d34b0dea86780a31d
      provider
      NCBI PubMed ESummary
      record sha256
      ec22ef91f2d904ae4e86018f25a33f6d70acc978f998f1bbe8eb5e3c6dda869b
      response sha256
      11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
      retrieved at
      2026-09-09T23:47:15.495091+00:00
      publication date
      display
      2015 Dec 20
      precision
      day
      year
      2015
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/26573069/
      title
      Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas.

      Preserved source evidence · Not medical advice